# GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)

> **NCT03890432** · NA · COMPLETED · sponsor: **HEIDEGGER CP** · enrollment: 213 (actual)

## Conditions studied

- Critical Illness
- Energy Supply; Deficiency, Severe
- Protein Deficiency
- Hypoglycemia
- Hyperglycemia

## Interventions

- **DEVICE:** GLUCOSAFE 2
- **DEVICE:** Local protocol control group with routine care
- **DEVICE:** Historical control group with routine care

## Key facts

- **NCT ID:** NCT03890432
- **Lead sponsor:** HEIDEGGER CP
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-10
- **Primary completion:** 2025-01-26
- **Final completion:** 2025-01-26
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03890432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03890432, "GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03890432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*